Navigation Links
invivodata Offers Complimentary PRO Gap Analysis

Patient Reported Outcome analysis and deeper insight into FDA Final Guidance

Pittsburgh (Vocus) March 24, 2010 -- invivodata inc., the industry leader in patient reported outcomes (PRO) solutions and services for global clinical research, along with its scientific and regulatory consulting division,PRO Consulting, today announced a limited time, complimentary PRO Gap Analysis service to help pharmaceutical research teams better understand what they should be doing differently in light of the FDA's final Guidance on PROs in clinical research.

The 60-minute PRO Gap Analysis presents an opportunity for pharmaceutical and medical device researchers to speak with Senior PRO Scientists to assess what will be expected of them in their clinical research and PRO data from a regulatory standpoint. During these complimentary teleconferences, scientific and regulatory experts from PRO Consulting will also discuss what reasonable steps researchers can take to address any gaps and reduce overall risk in their programs related to patient reported outcomes.

Biopharmaceutical researchers can also participate in complimentary in-person PRO Gap Analysis meetings by attending PROficiency™ 2010- the 3rd annual Patient Reported Outcomes conference hosted by invivodata. This educational conference, which begins April 28 in Ft. Lauderdale, FL, brings together international professionals involved in the scientific, strategic, operational, and regulatory aspects of PROs in clinical research. In addition to receiving specific direction on complying with the final FDA Guidance, attendees will come away from the conference with the knowledge to identify, select, and develop PRO instruments that are “fit for purpose” for specific program objectives and to integrate ePRO seamlessly into their clinical operations. For additional information and to register for PROficiency 2010, please visit

"invivodata’s PRO Consulting scientists have long contributed to and tracked the regulations and guidance surrounding patient-reported data collection in clinical research," said Dr. Jean Paty, invivodata Co-founder and Vice President of Scientific, Quality, and Regulatory Affairs. "We are pleased to offer the PRO Gap Analysis and share our expertise with clinical researchers as they work to understand the new FDA Guidance and make key decisions about their PRO strategies in global clinical development programs."
To request a complimentary PRO Gap Analysis teleconference, please visit

About invivodata inc.
invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata’s electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata’s solutions include comprehensive trial-support services that facilitate the collection of ePRO data, web-based access to study data and operational reports that give researchers and sponsors visibility into study progress, and scientific and regulatory consulting on the use of PRO data in a regulated environment. invivodata’s solution has been used in more than 275 clinical programs and is the industry-leading ePRO system in delivering primary efficacy data for FDA drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, Calif., USA. For more information visit

About PRO Consulting
PRO Consulting, a division of invivodata, inc., provides consulting services to help clinical research teams effectively develop, execute, and document patient reported outcome (PRO) strategies to support their clinical research objectives. The PRO Consulting team has more than 140 years of cumulative experience in psychometrics, PRO study design, migrating and validating electronic solutions to collect PRO data, and has extensive experience working with the FDA and other regulatory bodies. For more information please visit


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. invivodata and PRO Consulting to Present at International Industry Events
2. invivodata Announces ePROficiency 2009 Web Seminar Series
3. Quintiles Selects invivodata as Primary Partner for ePRO Solutions; Collaboration to Enhance Value, Effectiveness and Speed in Drug Development
4. invivodata Opens Registration for 3rd Annual Patient Reported Outcomes Conference
5. INC Research and invivodata Announce ePRO Partnership
6. New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation
7. Radio wave cooling offers new twist on laser cooling
8. Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015
9. Deloitte Leadership Offers Crucial Convergence Considerations for Life Sciences Companies
10. Microtest Offers Free White Paper: Virus Testing for Biological Products: Partnering With a Contract Lab
11. HollisterStier Offers Comfort With New ComforTen(TM) Multiple Skin Testing Device
Post Your Comments:
(Date:11/30/2015)... Zenith Epigenetics Corp. ("Zenith" or the "Company") today announced that ... its Board of Directors to replace Dr. Peter Johann ... experience as co-founder of Resverlogix, with expertise in the fields ... --> Dr. Wong remarked, "I am very excited ... standing expertise in epigenetics and the advanced stage of the ...
(Date:11/30/2015)... , November 30, 2015 TapImmune, ... the development of innovative peptide and gene-based immunotherapeutics and ... today announced it will be presenting at the 8 ... 1, 2015 at 2.30 PM PT. Dr. John ... Advisor will be giving the presentation and will join ...
(Date:11/30/2015)... BETHESDA, Md. , Nov. 30, 2015  Northwest ... biotechnology company developing DCVax® personalized immune therapies for solid ... to adding an additional independent director, and the Company ... investigation of allegations in a recent anonymous internet report ... on both initiatives. Linda Powers stated, ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... includes over 2,000 technical presentations offered in symposia, oral sessions, workshops, awards, and ... covers a wide range of applications such as, but not limited to, biotechnology, ...
Breaking Biology Technology:
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
(Date:10/27/2015)... NEW YORK , Oct. 27, 2015 ... the major issues of concern for various industry verticals ... This is due to the growing demand for secure ... practices in various ,sectors, such as hacking of bank ... concerns for electronic equipment such as PC,s, laptops, and ...
Breaking Biology News(10 mins):